{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T19:41:40Z","timestamp":1768074100872,"version":"3.49.0"},"reference-count":60,"publisher":"Keio Journal of Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med.","Keio j. med"],"published-print":{"date-parts":[[2025]]},"DOI":"10.2302\/kjm.2025-0002-ir","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:08:14Z","timestamp":1748369294000},"page":"177-188","source":"Crossref","is-referenced-by-count":1,"title":["Pemphigus: An Autoimmune Disease Model for Understanding the Role of          Autoreactive T Cells"],"prefix":"10.2302","volume":"74","author":[{"given":"Hayato","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Dermatology, Keio University School of Medicine, Tokyo,              Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kasperkiewicz M, Ellebrecht CT, Takahashi H,          Yamagami J, Zillikens D, Payne AS, Amagai M: Pemphigus. Nat Rev Dis Primers 2017; 3:          17026. PMID:28492232 https:\/\/doi.org\/10.1038\/nrdp.2017.26","DOI":"10.1038\/nrdp.2017.26"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Stanley JR, Amagai M: Pemphigus, bullous          impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 2006; 355: 1800\u20131810.          PMID:17065642 https:\/\/doi.org\/10.1056\/NEJMra061111","DOI":"10.1056\/NEJMra061111"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3.Amagai M, Tsunoda K, Zillikens D, Nagai T,          Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein          autoantibody profile. J Am Acad Dermatol 1999; 40 : 167\u2013170.          https:\/\/doi.org\/10.1016\/s0190-9622(99)70183-0","DOI":"10.1016\/S0190-9622(99)70183-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Amagai M: Desmoglein as a target in autoimmunity          and infection. J Am Acad Dermatol 2003; 48: 244\u2013252. PMID:12582396          https:\/\/doi.org\/10.1067\/mjd.2003.7","DOI":"10.1067\/mjd.2003.7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Schmidt E, Kasperkiewicz M, Joly P: Pemphigus.          Lancet 2019; 394: 882\u2013894. PMID:31498102          https:\/\/doi.org\/10.1016\/S0140-6736(19)31778-7","DOI":"10.1016\/S0140-6736(19)31778-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ishii N, Teye K, Fukuda S, Uehara R, Hachiya T,          Koga H, Tsuchisaka A, Numata S, Ohyama B, Tateishi C, Tsuruta D, Furumura M, Hattori S,          Kawakami T, Ohata C, Hashimoto T: Anti-desmocollin autoantibodies in nonclassical          pemphigus. Br J Dermatol 2015; 173: 59\u201368. PMID:25640111          https:\/\/doi.org\/10.1111\/bjd.13711","DOI":"10.1111\/bjd.13711"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hashimoto T, Kiyokawa C, Mori O, Miyasato M,          Chidgey MA, Garrod DR, Kobayashi Y, Komori K, Ishii K, Amagai M, Nishikawa T: Human          desmocollin 1 (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA          pemphigus. J Invest Dermatol 1997; 109: 127\u2013131. PMID:9242496          https:\/\/doi.org\/10.1111\/1523-1747.ep12319025","DOI":"10.1111\/1523-1747.ep12319025"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mindorf S, Dettmann IM, Kr\u00fcger S, Fuhrmann T,          Rentzsch K, Karl I, Probst C, Komorowski L, Fechner K, van Beek N, Lemcke S, S\u00e1rdy M,          Bangert C, Benoit S, Hashimoto T, Zillikens D, Pas HH, Jonkman MF, St\u00f6cker W, Schmidt E,          International Autoimmune Bullous Diseases Study Group: Routine detection of serum          antidesmocollin autoantibodies is only useful in patients with atypical pemphigus. Exp          Dermatol 2017; 26: 1267\u20131270. PMID:28815795          https:\/\/doi.org\/10.1111\/exd.13409","DOI":"10.1111\/exd.13409"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Koulu L, Kusumi A, Steinberg MS, Klaus-Kovtun V,          Stanley JR: Human autoantibodies against a desmosomal core protein in pemphigus foliaceus.          J Exp Med 1984; 160: 1509\u20131518. PMID:6491602          https:\/\/doi.org\/10.1084\/jem.160.5.1509","DOI":"10.1084\/jem.160.5.1509"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Amagai M, Klaus-Kovtun V, Stanley JR:          Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of          cell adhesion. Cell 1991; 67: 869\u2013877. PMID:1720352          https:\/\/doi.org\/10.1016\/0092-8674(91)90360-B","DOI":"10.1016\/0092-8674(91)90360-B"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz          LA: Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with          the disease. N Engl J Med 1982; 306: 1189\u20131196. PMID:7040962          https:\/\/doi.org\/10.1056\/NEJM198205203062001","DOI":"10.1056\/NEJM198205203062001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Amagai M, Karpati S, Prussick R, Klaus-Kovtun V,          Stanley JR: Autoantibodies against the amino-terminal cadherin-like binding domain of          pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992; 90: 919\u2013926. PMID:1522242          https:\/\/doi.org\/10.1172\/JCI115968","DOI":"10.1172\/JCI115968"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Amagai M, Tsunoda K, Suzuki H, Nishifuji K,          Koyasu S, Nishikawa T: Use of autoantigen-knockout mice in developing an active autoimmune          disease model for pemphigus. J Clin Invest 2000; 105: 625\u2013631. PMID:10712434          https:\/\/doi.org\/10.1172\/JCI8748","DOI":"10.1172\/JCI8748"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ahmed AR, Yunis EJ, Khatri K, Wagner R, Notani G,          Awdeh Z, Alper CA: Major histocompatibility complex haplotype studies in Ashkenazi Jewish          patients with pemphigus vulgaris. Proc Natl Acad Sci USA 1990; 87: 7658\u20137662. PMID:2217197          https:\/\/doi.org\/10.1073\/pnas.87.19.7658","DOI":"10.1073\/pnas.87.19.7658"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Miyagawa S, Higashimine I, Iida T, Yamashina Y,          Fukumoto T, Shirai T: HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility          to pemphigus among Japanese. J Invest Dermatol 1997; 109: 615\u2013618. PMID:9347787          https:\/\/doi.org\/10.1111\/1523-1747.ep12337585","DOI":"10.1111\/1523-1747.ep12337585"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yan L, Wang JM, Zeng K: Association between          HLA\u2010DRB1 polymorphisms and pemphigus vulgaris: a meta\u2010analysis. Br J Dermatol 2012; 167:          768\u2013777. PMID:22564118 https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11040.x","DOI":"10.1111\/j.1365-2133.2012.11040.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Di Zenzo G, Di Lullo G, Corti D, Calabresi V,          Sinistro A, Vanzetta F, Didona B, Cianchini G, Hertl M, Eming R, Amagai M, Ohyama B,          Hashimoto T, Sloostra J, Sallusto F, Zambruno G, Lanzavecchia A: Pemphigus autoantibodies          generated through somatic mutations target the desmoglein-3 cis-interface. J Clin Invest          2012; 122: 3781\u20133790. PMID:22996451 https:\/\/doi.org\/10.1172\/JCI64413","DOI":"10.1172\/JCI64413"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Futei Y, Amagai M, Ishii K, Kuroda-Kinoshita K,          Ohya K, Nishikawa T: Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and          foliaceus. J Dermatol Sci 2001; 26: 55\u201361. PMID:11323221          https:\/\/doi.org\/10.1016\/S0923-1811(00)00158-4","DOI":"10.1016\/S0923-1811(00)00158-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jones CC, Hamilton RG, Jordon RE: Subclass          distribution of human IgG autoantibodies in pemphigus. J Clin Immunol 1988; 8: 43\u201349.          PMID:3284896 https:\/\/doi.org\/10.1007\/BF00915155","DOI":"10.1007\/BF00915155"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tsunoda K, Ota T, Suzuki H, Ohyama M, Nagai T,          Nishikawa T, Amagai M, Koyasu S: Pathogenic autoantibody production requires loss of          tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.          Eur J Immunol 2002; 32: 627\u2013633. PMID:11857336          https:\/\/doi.org\/10.1002\/1521-4141(200203)32:3&lt;627::AID-IMMU627&gt;3.0.CO;2-1","DOI":"10.1002\/1521-4141(200203)32:3<627::AID-IMMU627>3.0.CO;2-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Veldman C, Stauber A, Wassmuth R, Uter W, Schuler          G, Hertl M: Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in          patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II          alleles. J Immunol 2003; 170: 635\u2013642. PMID:12496453          https:\/\/doi.org\/10.4049\/jimmunol.170.1.635","DOI":"10.4049\/jimmunol.170.1.635"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lin MS, Swartz SJ, Lopez A, Ding X,          Fernandez-Vina MA, Stastny P, Fairley JA, Diaz LA: Development and characterization of          desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest 1997;          99: 31\u201340. PMID:9011573 https:\/\/doi.org\/10.1172\/JCI119130","DOI":"10.1172\/JCI119130"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Takahashi H, Amagai M, Nishikawa T, Fujii Y,          Kawakami Y, Kuwana M: Novel system evaluating in vivo pathogenicity of desmoglein          3-reactive T cell clones using murine pemphigus vulgaris. J Immunol 2008; 181: 1526\u20131535.          PMID:18606708 https:\/\/doi.org\/10.4049\/jimmunol.181.2.1526","DOI":"10.4049\/jimmunol.181.2.1526"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Crotty S: T follicular helper cell          differentiation, function, and roles in disease. Immunity 2014; 41: 529\u2013542. PMID:25367570          https:\/\/doi.org\/10.1016\/j.immuni.2014.10.004","DOI":"10.1016\/j.immuni.2014.10.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon          J, MacLennan IC: Mechanism of antigen-driven selection in germinal centres. Nature 1989;          342: 929\u2013931. PMID:2594086 https:\/\/doi.org\/10.1038\/342929a0","DOI":"10.1038\/342929a0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Eming R, Hennerici T, B\u00e4cklund J, Feliciani C,          Visconti KC, Willenborg S, Wohde J, Holmdahl R, S\u00f8nderstrup G, Hertl M: Pathogenic IgG          antibodies against desmoglein 3 in pemphigus vulgaris are regulated by          HLA-DRB1*04:02-restricted T cells. J Immunol 2014; 193: 4391\u20134399. PMID:25252957          https:\/\/doi.org\/10.4049\/jimmunol.1401081","DOI":"10.4049\/jimmunol.1401081"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Didona D, Scarsella L, Hudemann C, Volkmann K,          Zimmer CL, Beckert B, Tikkanen R, Korff V, K\u00fchn K, Wienzek-Lischka S, Bein G, Di Zenzo G,          B\u00f6hme J, Cunha T, Solimani F, Pieper J, Juratli HA, G\u00f6bel M, Schmidt T, Borradori L, Yazdi          AS, Sitaru C, Garn H, Eming R, Fleischer S, Hertl M: Type 2 T-cell responses against          distinct epitopes of the desmoglein 3 ectodomain in pemphigus vulgaris. J Invest Dermatol          2024; 144: 263\u2013272. PubMed https:\/\/doi.org\/10.1016\/j.jid.2023.07.025","DOI":"10.1016\/j.jid.2023.07.025"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hudemann C, Maglie R, Llamazares-Prada M, Beckert          B, Didona D, Tikkanen R, Schmitt T, Hashimoto T, Waschke J, Hertl M, Eming R: Human          desmocollin 3\u2012specific IgG antibodies are pathogenic in a humanized HLA class II          transgenic mouse model of pemphigus. J Invest Dermatol 2022; 142: 915\u2013923. PMID:34265330          https:\/\/doi.org\/10.1016\/j.jid.2021.06.017","DOI":"10.1016\/j.jid.2021.06.017"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hogquist KA, Baldwin TA, Jameson SC: Central          tolerance: learning self-control in the thymus. Nat Rev Immunol 2005; 5: 772\u2013782.          PMID:16200080 https:\/\/doi.org\/10.1038\/nri1707","DOI":"10.1038\/nri1707"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Krangel MS: Mechanics of T cell receptor gene          rearrangement. Curr Opin Immunol 2009; 21: 133\u2013139. PMID:19362456          https:\/\/doi.org\/10.1016\/j.coi.2009.03.009","DOI":"10.1016\/j.coi.2009.03.009"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Klein L, Kyewski B, Allen PM, Hogquist KA:          Positive and negative selection of the T cell repertoire: what thymocytes see (and don\u2019t          see). Nat Rev Immunol 2014; 14: 377\u2013391. PMID:24830344          https:\/\/doi.org\/10.1038\/nri3667","DOI":"10.1038\/nri3667"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Owen DL, Sjaastad LE, Farrar MA: Regulatory T          cell development in the thymus. J Immunol 2019; 203: 2031\u20132041. PMID:31591259          https:\/\/doi.org\/10.4049\/jimmunol.1900662","DOI":"10.4049\/jimmunol.1900662"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Moran AE, Hogquist KA: T\u2010cell receptor affinity          in thymic development. Immunology 2012; 135: 261\u2013267. PMID:22182461          https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03547.x","DOI":"10.1111\/j.1365-2567.2011.03547.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34.Wada N, Nishifuji K, Yamada T,Kudoh J N          Peltonen MPeltonen Nagafuchi LNagafuchi Amagai SAmagai MAire-dependent thymic expression          of desmoglein 3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance.          J Invest Dermatol 2011;131:410\u2013417. https:\/\/doi.org\/10.1038\/jid.2010.330.","DOI":"10.1038\/jid.2010.330"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Takahashi H, Kouno M, Nagao K, Wada N, Hata T,          Nishimoto S, Iwakura Y, Yoshimura A, Yamada T, Kuwana M, Fujii H, Koyasu S, Amagai M:          Desmoglein 3\u2013specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in          mice. J Clin Invest 2011; 121: 3677\u20133688. PMID:21821914          https:\/\/doi.org\/10.1172\/JCI57379","DOI":"10.1172\/JCI57379"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Malissen M, Trucy J, Letourneur F, Reba\u00ef N, Dunn          DE, Fitch FW, Hood L, Malissen B: A T cell clone expresses two T cell receptor \u03b1 genes but          uses one \u03b1\u03b2 heterodimer for allorecognition and self MHC-restricted antigen recognition.          Cell 1988; 55: 49\u201359. PMID:3262424          https:\/\/doi.org\/10.1016\/0092-8674(88)90008-6","DOI":"10.1016\/0092-8674(88)90008-6"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Gascoigne NR, Alam SM: Allelic exclusion of the T          cell receptor \u03b1-chain: developmental regulation of a post-translational event. Semin          Immunol 1999; 11: 337\u2013347. PMID:10497088          https:\/\/doi.org\/10.1006\/smim.1999.0190","DOI":"10.1006\/smim.1999.0190"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Malissen M, Trucy J, Jouvin-Marche E, Cazenave          PA, Scollay R, Malissen B: Regulation of TCR \u03b1 and \u03b2 gene allelic exclusion during T-cell          development. Immunol Today 1992; 13: 315\u2013322. PMID:1324691          https:\/\/doi.org\/10.1016\/0167-5699(92)90044-8","DOI":"10.1016\/0167-5699(92)90044-8"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Nishimoto S, Kotani H, Tsuruta S, Shimizu N, Ito          M, Shichita T, Morita R, Takahashi H, Amagai M, Yoshimura A: Th17 cells carrying TCR          recognizing epidermal autoantigen induce psoriasis-like skin inflammation. J Immunol 2013;          191: 3065\u20133072. PMID:23956432 https:\/\/doi.org\/10.4049\/jimmunol.1300348","DOI":"10.4049\/jimmunol.1300348"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Sano S, Chan KS, Carbajal S, Clifford J, Peavey          M, Kiguchi K, Itami S, Nickoloff BJ, DiGiovanni J: Stat3 links activated keratinocytes and          immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat          Med 2005; 11: 43\u201349. PMID:15592573 https:\/\/doi.org\/10.1038\/nm1162","DOI":"10.1038\/nm1162"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Uto-Konomi A, Miyauchi K, Ozaki N, Motomura Y,          Suzuki Y, Yoshimura A, Suzuki S, Cua D, Kubo M: Dysregulation of suppressor of cytokine          signaling 3 in keratinocytes causes skin inflammation mediated by interleukin-20          receptor-related cytokines. PLoS One 2012; 7: e40343. PMID:22792286          https:\/\/doi.org\/10.1371\/journal.pone.0040343","DOI":"10.1371\/journal.pone.0040343"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Iriki H, Takahashi H, Wada N, Nomura H, Mukai M,          Kamata A, Ito H, Yamagami J, Matsui T, Kurebayashi Y, Mise-Omata S, Nishimasu H, Nureki O,          Yoshimura A, Hori S, Amagai M: Peripheral tolerance by Treg via constraining OX40 signal          in autoreactive T cells against desmoglein 3, a target antigen in pemphigus. Proc Natl          Acad Sci USA 2021; 118: e2026763118. PMID:34848535          https:\/\/doi.org\/10.1073\/pnas.2026763118","DOI":"10.1073\/pnas.2026763118"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Hayatsu N, Miyao T, Tachibana M, Murakami R,          Kimura A, Kato T, Kawakami E, Endo TA, Setoguchi R, Watarai H, Nishikawa T, Yasuda T,          Yoshida H, Hori S: Analyses of a mutant Foxp3 allele reveal BATF as a critical          transcription factor in the differentiation and accumulation of tissue regulatory T cells.          Immunity 2017; 47: 268\u2013283.e9. PMID:28778586          https:\/\/doi.org\/10.1016\/j.immuni.2017.07.008","DOI":"10.1016\/j.immuni.2017.07.008"},{"key":"44","unstructured":"44. Godfrey VL, Wilkinson JE, Russell LB: X-linked          lymphoreticular disease in the scurfy (sf) mutant mouse. Am J Pathol 1991; 138: 1379\u20131387.          PMID:2053595"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Kim JH, Kim SC: Paraneoplastic pemphigus:          paraneoplastic autoimmune disease of the skin and mucosa. Front Immunol 2019; 10: 1259.          PMID:31214197 https:\/\/doi.org\/10.3389\/fimmu.2019.01259","DOI":"10.3389\/fimmu.2019.01259"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Antiga E, Bech R, Maglie R, Genovese G, Borradori          L, Bockle B, Caproni M, Caux F, Chandran NS, Corr\u00e0 A, D\u2019Amore F, Daneshpazhooh M, De D,          Didona D, Dmochowski M, Drenovska K, Ehrchen J, Feliciani C, Goebeler M, Groves R, G\u00fcnther          C, Handa S, Hofmann SC, Horvath B, Ioannidis D, Jedlickova H, Kowalewski C, Kridin K, Joly          P, Lim YL, Marinovic B, Maverakis E, Meijer J, Patsatsi A, Pincelli C, Prost C,          Setterfield J, Sprecher E, Skiljevic D, Tasanen K, Uzun S, Van Beek N, Vassileva S,          Vorobyev A, Vujic I, Wang G, Wang M, Wozniak K, Yayli S, Zambruno G, Hashimoto T, Schmidt          E, Mascar\u00f2 JM, Marzano AV: S2k guidelines on the management of paraneoplastic          pemphigus\/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy          of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 2023; 37: 1118\u20131134.          PMID:36965110 https:\/\/doi.org\/10.1111\/jdv.18931","DOI":"10.1111\/jdv.18931"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Kaplan I, Hodak E, Ackerman L, Mimouni D, Anhalt          GJ, Calderon S: Neoplasms associated with paraneoplastic pemphigus: a review with emphasis          on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol 2004; 40:          553\u2013562. PMID:15063382 https:\/\/doi.org\/10.1016\/j.oraloncology.2003.09.020","DOI":"10.1016\/j.oraloncology.2003.09.020"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Ohzono A, Sogame R, Li X, Teye K, Tsuchisaka A,          Numata S, Koga H, Kawakami T, Tsuruta D, Ishii N, Hashimoto T: Clinical and immunological          findings in 104 cases of paraneoplastic pemphigus. Br J Dermatol 2015; 173: 1447\u20131452.          PMID:26358412 https:\/\/doi.org\/10.1111\/bjd.14162","DOI":"10.1111\/bjd.14162"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Lehman VT, Barrick BJ, Pittelkow MR, Peller PJ,          Camilleri MJ, Lehman JS: Diagnostic imaging in paraneoplastic autoimmune multiorgan          syndrome: retrospective single site study and literature review of 225 patients. Int J          Dermatol 2015; 54: 424\u2013437. PMID:25069905          https:\/\/doi.org\/10.1111\/ijd.12603","DOI":"10.1111\/ijd.12603"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Amber KT, Valdebran M, Grando SA: Paraneoplastic          autoimmune multiorgan syndrome (PAMS): beyond the single phenotype of paraneoplastic          pemphigus. Autoimmun Rev 2018; 17: 1002\u20131010. PMID:30103046          https:\/\/doi.org\/10.1016\/j.autrev.2018.04.008","DOI":"10.1016\/j.autrev.2018.04.008"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Eun Lee S, Ryoung Kim H, Hashimoto T, Kim SC:          Paraneoplastic pemphigus developed shortly after resection of follicular dendritic cell          sarcoma. Acta Derm Venereol 2008; 88: 410\u2013412. PMID:18709322          https:\/\/doi.org\/10.2340\/00015555-0446","DOI":"10.2340\/00015555-0446"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Kim SC, Chang SN, Lee IJ, Park SD, Jeong ET, Lee          CW, Ahn CM, Anhalt GJ: Localized mucosal involvement and severe pulmonary involvement in a          young patient with paraneoplastic pemphigus associated with Castleman\u2019s tumour. Br J          Dermatol 1998; 138: 667\u2013671. PMID:9640377          https:\/\/doi.org\/10.1046\/j.1365-2133.1998.02183.x","DOI":"10.1046\/j.1365-2133.1998.02183.x"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Kelly S, Schifter M, Fulcher DA, Lin MW:          Paraneoplastic pemphigus: two cases of intra\u2010abdominal malignancy presenting solely as          treatment refractory oral ulceration. J Dermatol 2015; 42: 300\u2013304. PMID:25557248          https:\/\/doi.org\/10.1111\/1346-8138.12753","DOI":"10.1111\/1346-8138.12753"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Anhalt GJ: Paraneoplastic pemphigus. J Investig          Dermatol Symp Proc 2004; 9: 29\u201333. PMID:14870982          https:\/\/doi.org\/10.1111\/j.1087-0024.2004.00832.x","DOI":"10.1111\/j.1087-0024.2004.00832.x"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Martel P, Loiseau P, Joly P, Busson M, Lepage V,          Mouquet H, Courville P, Flageul B, Charron D, Musette P, Gilbert D, Tron F: Paraneoplastic          pemphigus is associated with the DRB1*03 allele. J Autoimmun 2003; 20: 91\u201395.          PMID:12604316 https:\/\/doi.org\/10.1016\/S0896-8411(02)00092-6","DOI":"10.1016\/S0896-8411(02)00092-6"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Liu Q, Bu DF, Li D, Zhu XJ: Genotyping of HLA-I          and HLA-II alleles in Chinese patients with paraneoplastic pemphigus. Br J Dermatol 2008;          158: 587\u2013591. PMID:18070207          https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08361.x","DOI":"10.1111\/j.1365-2133.2007.08361.x"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Lee J, Bloom R, Amber KT: A systematic review of          patients with mucocutaneous and respiratory complications in paraneoplastic autoimmune          multiorgan syndrome: Castleman\u2019s disease is the predominant malignancy. Lung 2015; 193:          593\u2013596. PMID:25903794 https:\/\/doi.org\/10.1007\/s00408-015-9732-8","DOI":"10.1007\/s00408-015-9732-8"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Markopoulou KD, Cool CD, Elliot TL, Lynch DA,          Newell JD, Hale VA, Brown KK, Schwarz MI, Tuder RM: Obliterative bronchiolitis: varying          presentations and clinicopathological correlation. Eur Respir J 2002; 19: 20\u201330.          PMID:11843321 https:\/\/doi.org\/10.1183\/09031936.02.00282001","DOI":"10.1183\/09031936.02.00282001"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Hata T, Nishimoto S, Nagao K, Takahashi H,          Yoshida K, Ohyama M, Yamada T, Asano K, Amagai M: Ectopic expression of epidermal antigens          renders the lung a target organ in paraneoplastic pemphigus. J Immunol 2013; 191: 83\u201390.          PMID:23729442 https:\/\/doi.org\/10.4049\/jimmunol.1203536","DOI":"10.4049\/jimmunol.1203536"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Hoffman MA, Qiao X, Anhalt GJ: CD8+ T lymphocytes          in bronchiolitis obliterans, paraneoplastic pemphigus, and solitary Castleman\u2019s disease. N          Engl J Med 2003; 349: 407\u2013408. PMID:12878753          https:\/\/doi.org\/10.1056\/NEJM200307243490421","DOI":"10.1056\/NEJM200307243490421"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/74\/4\/74_2025-0002-IR\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:06:38Z","timestamp":1766808398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/74\/4\/74_2025-0002-IR\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.2025-0002-ir","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2025-0002-IR"}}